Growth Retardation In Children With Special Pathological Conditions Or Disease

• Status: Completed
• Trial end date: 2011-10-01
• Target enrollment: 0
• Participant gender: All

Summary

To show an increase in annual growth rate 3 years after Visit 2. Annual growth rate in standard deviation (SD) after 3 years will be compared to growth rate before the start of GH treatment.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer

Criteria

Inclusion Criteria:

• Bone age < 13 years for a boy and < 11 years for a girl

• Naive child: Measured Height < -2.5 SD for CA

• Child currently treated by GH

Exclusion Criteria:

• Idiopathic short stature

• Syndrome known to be associated with an increased risk of cancer e.g. family history of adenomatous polyposis